1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-108.36%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9873.13%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-16129.65%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-12933.18%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-12933.18%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
24.22%
Share count expansion well above AGEN's 2.74%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
24.22%
Diluted share count expanding well above AGEN's 2.73%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-18.12%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
0.96%
Positive FCF growth while AGEN is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-63.71%
Negative 10Y OCF/share CAGR while AGEN stands at 94.45%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-63.71%
Negative 5Y OCF/share CAGR while AGEN is at 83.15%. Joel Greenblatt would question the firm’s operational model or cost structure.
-2899.60%
Negative 3Y OCF/share CAGR while AGEN stands at 67.43%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-30244.22%
Negative 10Y net income/share CAGR while AGEN is at 88.21%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-30244.22%
Negative 5Y net income/share CAGR while AGEN is 76.53%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-27789.91%
Negative 3Y CAGR while AGEN is 69.58%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-195.85%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-195.85%
Negative 5Y equity/share growth while AGEN is at 83.61%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
20.77%
Below 50% of AGEN's 68.52%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.33%
Negative asset growth while AGEN invests at 0.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
14.08%
Positive BV/share change while AGEN is negative. John Neff sees a clear edge over a competitor losing equity.
11.04%
Debt growth far above AGEN's 5.70%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
35.15%
R&D growth drastically higher vs. AGEN's 8.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3110.63%
SG&A growth well above AGEN's 16.88%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.